Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery for stage II-III esophageal squamous cell carcinoma

OBJECTIVE: Definitive chemoradiotherapy (CRT) remains the most commonly used treatment for locally advanced esophageal squamous cell carcinoma (SCC), owing to perceptions that esophagectomy offers an unclear survival advantage. We compare recurrence, overall survival (OS), and disease-free survival...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Thorac Cardiovasc Surg
Auteurs principaux: Barbetta, Arianna, Hsu, Meier, Tan, Kay See, Stefanova, Dessislava, Herman, Koby, Adusumilli, Prasad S., Bains, Manjit S., Bott, Matthew J., Isbell, James M., Janjigian, Yelena Y., Ku, Geoffrey Y., Park, Bernard J., Wu, Abraham J., Jones, David R., Molena, Daniela
Format: Artigo
Langue:Inglês
Publié: 2018
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5960990/
https://ncbi.nlm.nih.gov/pubmed/29548582
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtcvs.2018.01.086
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires